Atheln, Inc.

Atheln is a consulting and strategic development firm serving biopharma, biotech, and medtech companies. The firm offers customized, phase-appropriate solutions across the full product lifecycle, including product development strategy and planning, chemistry, manufacturing and controls (CMC), nonclinical development, clinical operations, regulatory affairs, quality assurance and compliance, project management, market research and analysis, commercial strategy, reimbursement and market access, and business development.

The team comprises over 100 industry-seasoned experts with 20–40 years of global strategic and operational experience. Atheln functions as an integrated extension of client development, commercial, or management teams, addressing competency gaps or serving as a full outsourced development partner. The firm's expertise spans small molecules, biologics (including protein therapeutics), oligonucleotides, radiopharmaceuticals, drug-device combination products, and ophthalmic formulations. Key technical competencies include analytical development, formulation development, process development, CMO oversight, regulatory submissions (IND, BLA, NDA, CTA, IMPD), and cGMP compliance.